Approval · Notice of Compliance 5824 · 1994
INAPSINE: Notice of Compliance 5824
Issued July 14, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5824
- Date
- July 14, 1994
- Company
- Janssen PharmaceuticaBeerse, Saone Et Loire, Belgium
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate manufacturing site
- Therapeutic class
- Neuroleptic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INAPSINE | Not yet assigned | — |
Medicinal ingredients
- DROPERIDOL 2.5 MG per ML